Research Update
Vitamin E for NAFLD and MASH: The PIVENS Trial and Why Hepatologists Still Prescribe 800 IU
Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD), affects roughly a quarter of adults globally. A subset progress to steatohepatitis (MASH) with fibrosis. Drug development…